Guided Therapeutics (GTHP) Net Income Growth (3y) (2013 - 2025)
Guided Therapeutics (GTHP) Net Income Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.35 Bn | 175.06 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 107.93 Bn | 98.71 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 67.82 Bn | 66.37 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 48.03 Bn | 44.36 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 27.90 Bn | 25.62 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.96 Bn | 20.83 Bn | 2.07 Bn | 280.49% |
| 10 | Guided Therapeutics | 20.78 Mn | 20.72 Mn | 458,000.00 | 12.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.32% |
| Sep 30, 2025 | 12.35% |
| Jun 30, 2025 | 4.32% |
| Mar 31, 2025 | 5.56% |
| Dec 31, 2024 | -13.66% |
| Sep 30, 2024 | -126.48% |
| Jun 30, 2024 | 11.82% |
| Mar 31, 2024 | 8.04% |
| Dec 31, 2023 | -29.63% |
| Sep 30, 2023 | -34.44% |
| Jun 30, 2023 | 38.67% |
| Mar 31, 2023 | -32.35% |
| Dec 31, 2022 | -54.23% |
| Sep 30, 2022 | -106.03% |
| Jun 30, 2022 | 29.68% |
| Mar 31, 2022 | -33.10% |
| Dec 31, 2021 | 45.49% |
| Sep 30, 2021 | 27.88% |
| Jun 30, 2021 | -32.05% |
| Mar 31, 2021 | -35.32% |